These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 29191685)
1. Breast MRI as a Problem-solving Study in the Evaluation of BI-RADS Categories 3 and 4 Microcalcifications: Is it Worth Performing? Shimauchi A; Machida Y; Maeda I; Fukuma E; Hoshi K; Tozaki M Acad Radiol; 2018 Mar; 25(3):288-296. PubMed ID: 29191685 [TBL] [Abstract][Full Text] [Related]
3. Predictive values of BI-RADS(®) magnetic resonance imaging (MRI) in the detection of breast ductal carcinoma in situ (DCIS). Badan GM; Piato S; Roveda D; de Faria Castro Fleury E Eur J Radiol; 2016 Oct; 85(10):1701-1707. PubMed ID: 27666605 [TBL] [Abstract][Full Text] [Related]
4. Mammographic features and correlation with biopsy findings using 11-gauge stereotactic vacuum-assisted breast biopsy (SVABB). Mendez A; Cabanillas F; Echenique M; Malekshamran K; Perez I; Ramos E Ann Oncol; 2004 Mar; 15(3):450-4. PubMed ID: 14998847 [TBL] [Abstract][Full Text] [Related]
5. Sensitivity of breast MRI for ductal carcinoma in situ appearing as microcalcifications only on mammography. Rinaldi P; Buccheri C; Giuliani M; Bufi E; Romani M; Patrolecco F; Belli P; Bonomo L Clin Imaging; 2016; 40(6):1207-1212. PubMed ID: 27618803 [TBL] [Abstract][Full Text] [Related]
6. The value of breast MRI for BI-RADS category 4B mammographic microcalcification: based on the 5 Eun NL; Son EJ; Gweon HM; Youk JH; Kim JA Clin Radiol; 2018 Aug; 73(8):750-755. PubMed ID: 29853301 [TBL] [Abstract][Full Text] [Related]
7. Is breast MRI a helpful additional diagnostic test in suspicious mammographic microcalcifications? Baltzer PAT; Bennani-Baiti B; Stöttinger A; Bumberger A; Kapetas P; Clauser P Magn Reson Imaging; 2018 Feb; 46():70-74. PubMed ID: 29122667 [TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value? Uematsu T; Yuen S; Kasami M; Uchida Y Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Breast Imaging Reporting and Data System Category 3 mammograms and the use of stereotactic vacuum-assisted breast biopsy in a nonacademic community practice. Mendez A; Cabanillas F; Echenique M; Malekshamran K; Perez I; Ramos E Cancer; 2004 Feb; 100(4):710-4. PubMed ID: 14770425 [TBL] [Abstract][Full Text] [Related]
10. Unveiling the potential of breast MRI: a game changer for BI-RADS 4A microcalcifications. Li S; Lin Y; Liu G; Shao Z; Yang Y Breast Cancer Res Treat; 2024 Jul; 206(2):425-435. PubMed ID: 38664289 [TBL] [Abstract][Full Text] [Related]
11. Usefulness and limitations of the Japan Mammography Guidelines for the categorization of microcalcifications. Uematsu T; Kasami M; Yuen S Breast Cancer; 2008; 15(4):291-7. PubMed ID: 18288569 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of malignancy risk stratification of microcalcifications detected on mammography: a study based on the 5th edition of BI-RADS. Kim SY; Kim HY; Kim EK; Kim MJ; Moon HJ; Yoon JH Ann Surg Oncol; 2015 Sep; 22(9):2895-901. PubMed ID: 25608770 [TBL] [Abstract][Full Text] [Related]
13. US and MRI in the evaluation of mammographic BI-RADS 4 and 5 microcalcifications. Hrkac Pustahija A; Ivanac G; Brkljacic B Diagn Interv Radiol; 2018 Jul; 24(4):187-194. PubMed ID: 30091708 [TBL] [Abstract][Full Text] [Related]
14. 3-T breast magnetic resonance imaging in patients with suspicious microcalcifications on mammography. Stehouwer BL; Merckel LG; Verkooijen HM; Peters NH; Mann RM; Duvivier KM; Mali WP; Peeters PH; Veldhuis WB; van den Bosch MA Eur Radiol; 2014 Mar; 24(3):603-9. PubMed ID: 24078055 [TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced breast MRI in patients with suspicious microcalcifications on mammography: results of a multicenter trial. Bazzocchi M; Zuiani C; Panizza P; Del Frate C; Soldano F; Isola M; Sardanelli F; Giuseppetti GM; Simonetti G; Lattanzio V; Del Maschio A AJR Am J Roentgenol; 2006 Jun; 186(6):1723-32. PubMed ID: 16714666 [TBL] [Abstract][Full Text] [Related]
16. MRI for the assessment of malignancy in BI-RADS 4 mammographic microcalcifications. Bennani-Baiti B; Dietzel M; Baltzer PA PLoS One; 2017; 12(11):e0188679. PubMed ID: 29190656 [TBL] [Abstract][Full Text] [Related]
17. A comparative study of the diagnostic value of contrast-enhanced breast MR imaging and mammography on patients with BI-RADS 3-5 microcalcifications. Li E; Li J; Song Y; Xue M; Zhou C PLoS One; 2014; 9(11):e111217. PubMed ID: 25365327 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the role of dynamic contrast-enhanced MR imaging for patients with BI-RADS 3-4 microcalcifications. Jiang Y; Lou J; Wang S; Zhao Y; Wang C; Wang D PLoS One; 2014; 9(6):e99669. PubMed ID: 24927476 [TBL] [Abstract][Full Text] [Related]
19. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging. Strobel K; Schrading S; Hansen NL; Barabasch A; Kuhl CK Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857 [TBL] [Abstract][Full Text] [Related]
20. [Stereotactic Mammotome breast biopsy: routine clinical experience and correlation with BI-RADS--classification and histopathology]. Michel SC; Löw R; Singer G; Otto R; Hohl M; Kubik RA Praxis (Bern 1994); 2007 Sep; 96(39):1459-74. PubMed ID: 17966279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]